Katherine Lind, MD, clinical fellow in our Pediatric Blood and Marrow Transplant and Cellular Therapy Program, is serving on behalf of Children’s Hospital Colorado within the IGNITE Consortium — a first-of-its-kind alliance of pediatric disparity investigators from across the United States that are working to advance the science of health equity research.
In her seventh year of training, Dr. Lind is passionate about finding ways to help kids survive cancer, whether through bone marrow treatments or addressing socioeconomic inequities.
Led by the Dana-Farber Cancer Institute with 14 physicians, 12 institutions and three parent representatives involved, IGNITE’s goal is to open trials to families and give doctors the resources and protected time to conduct them. Dr. Lind is currently involved with a clinical trial to identify how monetary assistance changes outcomes for poor children diagnosed with neuroblastoma.
“It’s exciting because it shows a commitment to address these issues and that people care so much that they’re willing to make a change,” says Dr. Lind.
This collaboration not only addresses social determinants of health but provides Children’s Colorado a wider variety of resources, brings providers together in support of care and opens the possibility for more cutting-edge therapies.
Featured researcher

Katherine T. Lind, MD, MS
Clinical fellow
Pediatrics-Hematology/Oncology and Bone Marrow Transplantation
University of Colorado School of Medicine